Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Solid Tumor × CD3 Complex × 90 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Solid Tumor 1

Interventions

tislelizumab 6 Injections 6 pembrolizumab 3 Nivolumab 3 toripalimab 2 Bevacizumab 2 zimberelimab 1 olaparib 1 erdafitinib 1 durvalumab 1 cemiplimab 1 avelumab 1 atezolizumab 1 Paclitaxel 1 Oxaliplatin 1 Leucovorin 1 Fluorouracil 1 Drug Therapy 1 CD3 Complex 1 BID protein, human 1 Appointments and Schedules 1 Antineoplastic Agents 1 APG-1387 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07408258 2026-02-13

Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors

OncoC4, Inc.

Phase 1 Not yet recruiting

Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡